3M Tegaderm 1633 Adult Peripheral I.V. High Secural Dressing is a reliable and widely-used medical dressing recommended for peripheral intravenous (I.V.) applications. Manufactured by 3M India Limited, a trusted name in the healthcare industry, this dressing falls under the category of Doctor’s Corner medications.
Each packet contains 1 film dressing measuring 8.5cm x 7cm, providing ample coverage and protection for I.V. sites. Priced at an MRP of Rs. 135, this dressing offers cost-effective yet high-quality care for patients requiring I.V. therapy.
Dosage instructions for 3M Tegaderm 1633 should be followed as per healthcare provider recommendations. While this dressing is typically safe and well-tolerated, some individuals may experience mild side effects such as skin irritation or redness at the application site.
Frequently Asked Questions:
Q: How should I apply 3M Tegaderm 1633 dressing?
A: Clean the I.V. site thoroughly before applying the dressing. Peel off the protective film and gently place the dressing over the site, ensuring proper adhesion for secure coverage.
Q: Can I shower with the 3M Tegaderm 1633 dressing on?
A: Yes, the dressing is designed to be water-resistant, allowing you to shower without compromising its effectiveness. However, avoid direct high-pressure water on the dressing.
Q: How often should I change the 3M Tegaderm 1633 dressing?
A: The dressing can typically be left in place for several days, depending on individual needs and healthcare provider recommendations. Monitor the site for any signs of infection or loosening of the dressing.
Q: Are there any specific storage conditions for the 3M Tegaderm 1633 dressing?
A: Store the dressing in a clean, dry place at room temperature. Avoid exposure to direct sunlight or extreme temperatures to maintain its integrity.
Q: What should I do if I experience persistent irritation or allergic reactions to the dressing?
A: If you notice any severe or prolonged skin reactions, discontinue use of the dressing and consult your healthcare provider for further guidance.
